News & Events about Tandem Diabetes Care Inc.
Latest Ratings for TNDM
DateFirmActionFromTo Feb 2022Wells FargoMaintainsOverweight Feb 2022CitigroupMaintainsBuy Feb 2022SVB LeerinkMaintainsMarket Perform
View More Analyst Ratings for TNDM
View the Latest Analyst Ratings
read more...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by Diabetes Technology & Therapeutics of a meta-analysis of three randomized controlled trials of its Control-IQ advanced hybrid closed-loop technology. Results...
Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced the completion of its previously announced acquisition of AMF Medical SA, the privately held Swiss developer of the Sigi Patch Pump. The Sigi Patch Pump, designed to be an ergonomic...
StockNews.com downgraded shares of Tandem Diabetes Care (NASDAQ:TNDM Get Rating) from a hold rating to a sell rating in a research note published on Friday morning. Several other equities analysts have also recently issued reports on the company. Raymond James decreased their price target on Tandem ...
Tandem Diabetes Care, Inc. (NASDAQ:TNDM Get Rating) COO David B. Berger sold 10,000 shares of Tandem Diabetes Care stock in a transaction on Friday, December 16th. The stock was sold at an average price of $40.25, for a total value of $402,500.00. Following the completion of the transaction, the ...